ME Life Science eSeminar 2020

On-demand
Life Science eSeminar

COVID-19 insights: Possible research solutions to help you accelerate the development of drugs, vaccines and therapies

Around the world, the coronavirus (COVID-19) pandemic situation is still escalating in many countries. Frontline epidemic prevention teams, medical personnel and scientific researchers are racing against time to complete testing quickly, safely and accurately, and to accelerate the development of drugs, vaccines and clinical research. The question now is how to improve the overall biosafety and reliability of laboratories for current virology research.

This eSeminar demonstrates how technology can help meet these needs. It brings together Beckman Coulter Life Sciences, Cytiva, Leica Microsystems, Molecular Devices, Pall, Phenomenex and SCIEX from Danaher Life Science Platform to share current cutting-edge research solutions that help accelerate the development of drugs, vaccines and therapies.

Agenda

Opening and welcome
Bouchra Bensaoud, President MEA and Turkey, Danaher
SaudiVax supporting the fight against COVID-19 in Saudi Arabia
Dr. Bodor Fallatah, Director of R&D, SaudiVax
Structural biology and advanced imaging centered on viral inhibitors
Dr. Luis Alvarez, Application Manager - Functional Imaging, Leica Microsystems
Research automation solutions during COVID-19 for viral extraction/detection and drug discovery/repurposing
Maria Savino, Marketing Manager, Beckman Coulter Life Sciences
Accelerating study of viral infection and therapeutics with microplate-based detection and high-throughput screening
Dr. Penny Tavormina, Applications Scientist, Molecular Devices
Mass spectrometry and capillary electrophoresis applications for virology research
Dr. Stephen Lock, Marketing and Market Development Manager, BioPharma, EMEAI, SCIEX
HPLC and LC-MS workflows to characterize COVID-19 therapeutics and vaccine development
Helen Whitby, PhD, Technical Specialist, Phenomenex
Approaches for the development and scale-up of vaccine manufacturing processes
Dr. Peter Levison, Executive Director Business Development, Pall Biotech
Extraction free chemistry for detection of RNA directly from samples
Harald Kraus, Sales Leader Emerging Markets, Cytiva
Putting our diagnostics team to work for you during the coronavirus pandemic
Chike Ejiofor, Global Applications Manager - Sample Prep, Cytiva
Conclusion and future events
Sean Daugherty, Regional Manager MEA, SCIEX

Watch now

By submitting your information, you agree that SCIEX may collect and further process your personal data in accordance with its Privacy Policy.
You may object to receiving further information at any time.

Related to RUO-MKT-06-12619-A
For research use only. Not for use in diagnostic procedures.